121 related articles for article (PubMed ID: 17827165)
1. Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation.
Karihtala P; Soini Y; Auvinen P; Tammi R; Tammi M; Kosma VM
J Histochem Cytochem; 2007 Dec; 55(12):1191-8. PubMed ID: 17827165
[TBL] [Abstract][Full Text] [Related]
2. Antioxidative response for nitric oxide production in breast carcinoma.
Karihtala P; Kinnula VL; Soini Y
Oncol Rep; 2004 Oct; 12(4):755-9. PubMed ID: 15375496
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan expression in differentiated thyroid carcinoma.
Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM
J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan.
Wernicke M; Piñeiro LC; Caramutti D; Dorn VG; Raffo MM; Guixa HG; Telenta M; Morandi AA
Mod Pathol; 2003 Feb; 16(2):99-107. PubMed ID: 12591961
[TBL] [Abstract][Full Text] [Related]
5. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
6. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
Anttila MA; Tammi RH; Tammi MI; Syrjänen KJ; Saarikoski SV; Kosma VM
Cancer Res; 2000 Jan; 60(1):150-5. PubMed ID: 10646867
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan.
Auvinen P; Tammi R; Tammi M; Johansson R; Kosma VM
Histopathology; 2005 Oct; 47(4):420-8. PubMed ID: 16178897
[TBL] [Abstract][Full Text] [Related]
8. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer.
Auvinen P; Tammi R; Kosma VM; Sironen R; Soini Y; Mannermaa A; Tumelius R; Uljas E; Tammi M
Int J Cancer; 2013 Feb; 132(3):531-9. PubMed ID: 22753277
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.
Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA
Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804
[TBL] [Abstract][Full Text] [Related]
10. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.
Auvinen P; Rilla K; Tumelius R; Tammi M; Sironen R; Soini Y; Kosma VM; Mannermaa A; Viikari J; Tammi R
Breast Cancer Res Treat; 2014 Jan; 143(2):277-86. PubMed ID: 24337597
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors.
Reveneau S; Arnould L; Jolimoy G; Hilpert S; Lejeune P; Saint-Giorgio V; Belichard C; Jeannin JF
Lab Invest; 1999 Oct; 79(10):1215-25. PubMed ID: 10532585
[TBL] [Abstract][Full Text] [Related]
15. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
16. High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
Tiainen S; Oikari S; Tammi M; Rilla K; Hämäläinen K; Tammi R; Kosma VM; Auvinen P
Breast Cancer Res Treat; 2016 Nov; 160(2):237-247. PubMed ID: 27683279
[TBL] [Abstract][Full Text] [Related]
17. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.
Auvinen P; Tammi R; Parkkinen J; Tammi M; Agren U; Johansson R; Hirvikoski P; Eskelinen M; Kosma VM
Am J Pathol; 2000 Feb; 156(2):529-36. PubMed ID: 10666382
[TBL] [Abstract][Full Text] [Related]
19. NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions.
Czesnikiewicz-Guzik M; Lorkowska B; Zapala J; Czajka M; Szuta M; Loster B; Guzik TJ; Korbut R
J Physiol Pharmacol; 2008 Mar; 59(1):139-52. PubMed ID: 18441394
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan.
Tammi RH; Kultti A; Kosma VM; Pirinen R; Auvinen P; Tammi MI
Semin Cancer Biol; 2008 Aug; 18(4):288-95. PubMed ID: 18468453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
